Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.54 |
| ▸ | TDO2 | P48775 | 3/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | PNMT | P11086 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | ACP3 | P15309 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | IDO2 | Q6ZQW0 | 2/20 | 0.43 |
| ▸ | CACNA2D1 | P54289 | 4/20 | 0.43 |
| ▸ | CACNA1B | Q00975 | 4/20 | 0.43 |
| ▸ | CACNB1 | Q02641 | 4/20 | 0.43 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27793513 | 0.85 | ACP3 (0.53) | IDO1TDO2CYP3A4CYP2D6NFKB1 | |
| SCHEMBL477580 | 0.85 | ACP3 (0.53) | IDO1TDO2CYP3A4CYP2D6NFKB1 | |
| SCHEMBL477602 | 0.85 | ACP3 (0.53) | IDO1TDO2CYP3A4CYP2D6NFKB1 | |
| SCHEMBL29609159 | 0.85 | ACP3 (0.53) | IDO1TDO2CYP3A4CYP2D6NFKB1 | |
| SCHEMBL5742922 | 0.83 | CYP2D6 (0.50) | IDO1TDO2CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL7809671 | 0.78 | MEN1 (0.63) | LMNAMEN1KMT2AMAPTCYP2C9 | |
| SCHEMBL7540828 | 0.78 | IDO1 (0.56) | IDO1TDO2CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL8804684 | 0.77 | SMN1; SMN2 (0.41) | IDO1TDO2ALDH1A1LMNAACP3 | |
| SCHEMBL19856483 | 0.76 | CYP1A2 (0.56) | IDO1TDO2CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL28905220 | 0.76 | IDO1 (0.54) | IDO1TDO2CYP1A2CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8563786-B2 | Method for producing optically active alcohol | MITSUI CHEMICALS, INC. (JP) | 2013-10-22 | — | — | US | disclosed |
| US-20120088938-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2012-04-12 | — | — | US | disclosed |
| EP-2412694-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | Mitsui Chemicals, Inc. (JP) | 2012-02-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088938-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | ADH1A, ADH1C, FHIT | IDO1 4327/4885TDO2 1885/4885CYP1A2 37/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.